Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

126,667 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Randomized, Double-Blinded, Placebo-Controlled Phase 2 Trial of an Inactivated Severe Acute Respiratory Syndrome Coronavirus 2 Vaccine in Healthy Adults.
Che Y, Liu X, Pu Y, Zhou M, Zhao Z, Jiang R, Yin Z, Xu M, Yin Q, Wang J, Pu J, Zhao H, Zhang Y, Wang L, Jiang Y, Lei J, Zheng Y, Liao Y, Long R, Yu L, Cui P, Yang H, Zhang Y, Li J, Chen W, He Z, Ma K, Hong C, Li D, Jiang G, Liu D, Xu X, Fan S, Cheng C, Zhao H, Yang J, Li Y, Zou Y, Zhu Y, Zhou Y, Guo Y, Yang T, Chen H, Xie Z, Li C, Li Q. Che Y, et al. Among authors: liu x, liu d. Clin Infect Dis. 2021 Dec 6;73(11):e3949-e3955. doi: 10.1093/cid/ciaa1703. Clin Infect Dis. 2021. PMID: 33165503 Free PMC article. Clinical Trial.
Immunogenicity and safety of the inactivated poliomyelitis vaccine made from Sabin strains in a phase IV clinical trial for the vaccination of a large population.
Jiang R, Liu X, Sun X, Wang J, Huang Z, Li C, Li Z, Zhou J, Pu Y, Ying Z, Yin Q, Zhao Z, Zhang L, Lei J, Bao W, Jiang Y, Dou Y, Li J, Yang H, Cai W, Deng Y, Che Y, Shi L, Sun M. Jiang R, et al. Among authors: liu x. Vaccine. 2021 Mar 1;39(9):1463-1471. doi: 10.1016/j.vaccine.2021.01.027. Epub 2021 Jan 22. Vaccine. 2021. PMID: 33487470 Free article. Clinical Trial.
Immunological non-inferiority and safety of a quadrivalent inactivated influenza vaccine versus two trivalent inactivated influenza vaccines in China: Results from two studies.
Liu X, Park J, Xia S, Liang B, Yang S, Wang Y, Syrkina O, Lavis N, Liu S, Zhao C, Ding J, Hu J, Samson SI, de Bruijn IA; FSQ01 and FSQ02 Study Groups. Liu X, et al. Among authors: liu s. Hum Vaccin Immunother. 2022 Nov 30;18(6):2132798. doi: 10.1080/21645515.2022.2132798. Epub 2022 Nov 3. Hum Vaccin Immunother. 2022. PMID: 36328438 Free PMC article. Clinical Trial.
Comparing recombinant human rabies monoclonal antibody (ormutivimab) with human rabies immunoglobulin (HRIG) for postexposure prophylaxis: A phase III, randomized, double-blind, non-inferiority trial.
Liu X, Li Y, Li J, Zhou J, Guo J, Pu Y, Jiang Y, Zhou Y, Jiang Z, Shu Q, Wang C, Wang J, Zhao Y, Zhao W, Wang H, Wei J, Yu H, Gao J, Li X. Liu X, et al. Int J Infect Dis. 2023 Sep;134:53-62. doi: 10.1016/j.ijid.2023.05.017. Epub 2023 May 19. Int J Infect Dis. 2023. PMID: 37211270 Free article. Clinical Trial.
Safety, immunogenicity, and efficacy of an mRNA COVID-19 vaccine (RQ3013) given as the fourth booster following three doses of inactivated vaccines: a double-blinded, randomised, controlled, phase 3b trial.
Liu X, Sun Z, Wang Z, Chen J, Wu Q, Zheng Y, Yang X, Mo L, Yan X, Li W, Zou Y, Song H, Qian F, Lu J, Zhou H, Wang Y, Xiang Z, Yu H, Lin J, Yuan L, Zheng Y. Liu X, et al. EClinicalMedicine. 2023 Sep 21;64:102231. doi: 10.1016/j.eclinm.2023.102231. eCollection 2023 Oct. EClinicalMedicine. 2023. PMID: 37767190 Free PMC article.
Immunogenicity and safety of inactivated enterovirus A71 vaccines in children aged 6-35 months in China: a non-inferiority, randomised controlled trial.
Li Y, Gao F, Wang Y, Li J, Zhang Y, Lv H, Wang S, Yang H, Liu X, Li K, Wang H, Yin Z, Liang Z, An Z, Mao Q, Feng Z. Li Y, et al. Among authors: liu x. Lancet Reg Health West Pac. 2021 Nov 2;16:100284. doi: 10.1016/j.lanwpc.2021.100284. eCollection 2021 Nov. Lancet Reg Health West Pac. 2021. PMID: 34881371 Free PMC article.
126,667 results
You have reached the last available page of results. Please see the User Guide for more information.